Literature DB >> 10430791

Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype.

C E Petersen1, C E Ha, K Harohalli, D S Park, J B Feix, O Isozaki, N V Bhagavan.   

Abstract

BACKGROUND: In a previous study, we found that the amino acid substitution R218H in human serum albumin (HSA) was the cause of familial dysalbuminemic hyperthyroxinemia (FDH) in several Caucasian patients. Subsequently the substitution R218P was shown to be the cause of FDH in several members of a Japanese family. This study attempts to resolve discrepancies in the only other study of R218P HSA and identifies two new Japanese R218P FDH patients unrelated to those described previously. METHODS AND
RESULTS: Recombinant R218H, R218P, and wild-type HSA were synthesized in yeast, and the affinities of these HSA species for l- and d-thyroxine were determined using fluorescence spectroscopy. The dissociation constants for the binding of wild-type, R218P, and R218H HSA to l-thyroxine were 1.44 x 10(-6), 2.64 x 10(-7), and 2.49 x 10(-7) mol/L, respectively. The circular dichroism spectra of thyroxine bound to R218H and R218P HSA were markedly different, indicating that the structure of the thyroxine/HSA complex is different for either protein.
CONCLUSIONS: The K(d) values for l-thyroxine bound to R218P and R218H HSA determined in this study were similar. The extremely high serum total-thyroxine concentrations reported previously for R218P FDH patients (10-fold higher than those reported for R218H FDH patients) are not consistent with the K(d) values determined in this study. Possible explanations for these discrepancies are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430791

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia.

Authors:  Isabelle Petitpas; Charles E Petersen; Chung-Eun Ha; Ananyo A Bhattacharya; Patricia A Zunszain; Jamie Ghuman; Nadhipuram V Bhagavan; Stephen Curry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

Review 3.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

4.  Redox-sensitivity and site-specificity of S- and N- denitrosation in proteins.

Authors:  Frances L Jourd'heuil; Anthony M Lowery; Elaina M Melton; Sanie Mnaimneh; Nathan S Bryan; Bernadette O Fernandez; Joo-Ho Park; Chung-Eun Ha; Nadhipuram V Bhagavan; Martin Feelisch; David Jourd'heuil
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

Review 5.  Clinical, Genetic, and Protein Structural Aspects of Familial Dysalbuminemic Hyperthyroxinemia and Hypertriiodothyroninemia.

Authors:  Ulrich Kragh-Hansen; Monica Galliano; Lorenzo Minchiotti
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-01       Impact factor: 5.555

6.  A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia.

Authors:  Nadia Schoenmakers; Carla Moran; Irene Campi; Maura Agostini; Olivia Bacon; Odelia Rajanayagam; John Schwabe; Sonia Bradbury; Timothy Barrett; Frank Geoghegan; Maralyn Druce; Paolo Beck-Peccoz; Angela O'Toole; Penelope Clark; Michelle Bignell; Greta Lyons; David Halsall; Mark Gurnell; Krishna Chatterjee
Journal:  J Clin Endocrinol Metab       Date:  2014-03-19       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.